Cargando…

Lipoprotein-associated phospholipase A2 (Lp-PLA2) – possible diagnostic and risk biomarker in chronic ischaemic heart disease

In a group of 208 patients with chronic ischaemic heart disease, the variation of A(2)-associated-LDL phosphatase (Lp-PLA(2)) serum concentration values was analysed in dynamics at a two-week interval. The conclusion of the study is that the values of serum concentration of Lp-PLA(2) can be accepted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diaconu, Adriana, Coculescu, Bogdan-Ioan, Manole, Gheorghe, Vultur, Horațiu, Coculescu, Elena Claudia, Stocheci, Cristina Maria, Tudorache, Ioan-Sorin, Dincă, Alexandra-Ligia, Dincă, Valeriu Gabi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671608/ https://www.ncbi.nlm.nih.gov/pubmed/33187461 http://dx.doi.org/10.1080/14756366.2020.1839447

Ejemplares similares

Osteopontin – a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease
por: Coculescu, Bogdan-Ioan, et al.
Publicado: (2019)

Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction
por: Coculescu, Bogdan Ioan, et al.
Publicado: (2018)

Adiponectin – stratification biomarker in diastolic cardiac dysfunction
por: Dincă, Valeriu-Gabi, et al.
Publicado: (2023)

Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators—a review
por: Dinca, Alexandra-Ligia, et al.
Publicado: (2023)

Gamma-glutamyltransferase, possible novel biomarker in colon diverticulosis: a case-control study
por: Bălăeţ, Constantin, et al.
Publicado: (2018)

Haemolytic anaemia and hepatocitolysis associated with hypermagnesaemia by repeated exposures to copper–calcium fungicides
por: Bălăeţ, Constantin, et al.
Publicado: (2017)

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A(2 )(Lp-PLA(2 )): a review
por: Silva, Isis T, et al.
Publicado: (2011)

Burning mouth syndrome: controversial place as a symptom of Oro-dental pathology
por: Coculescu, EC, et al.
Publicado: (2015)

Infectiile digestive cu Salmonella enterica subspecia enterica rezistente la antibiotice – o problema de sanatate publica
por: Bogdan Ioan, Coculescu, et al.
Publicado: (2014)

Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)): A Novel and Promising Biomarker for Cardiovascular Risks Assessment
por: Cai, Anping, et al.
Publicado: (2013)

Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
por: Passaro, Angelina, et al.
Publicado: (2018)

STABILITY and SOLID-TIMI 52: Lipoprotein associated phospholipase A(2) (Lp-PLA(2)) as a biomarker or risk factor for cardiovascular diseases
por: Hassan, Mohamed
Publicado: (2015)

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Yin, Yun-jie, et al.
Publicado: (2020)

Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in adolescents: the healthy young cross-sectional study
por: da Silva, Isis T, et al.
Publicado: (2013)

Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A(2) (Lp-PLA(2)) Inhibitor [(18)F]GSK2647544 in Healthy Male Subjects
por: Huiban, Mickael, et al.
Publicado: (2016)

Epidemiological and etiological aspects of burning mouth syndrome
por: Coculescu, EC, et al.
Publicado: (2014)

Lipoprotein-associated phospholipase A(2 )(Lp-PLA(2)) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
por: Detopoulou, Paraskevi, et al.
Publicado: (2009)

Resveratrol Treatment Is Associated with Lipid Regulation and Inhibition of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Rabbits Fed a High-Fat Diet
por: Xu, Lei, et al.
Publicado: (2020)

The concept of marketing in the public-private partnership in the medical system in Romania
por: Purcărea, VL, et al.
Publicado: (2014)

A strategy to identify opportunities for innovation in Romanian healthcare services
por: Coculescu, BI, et al.
Publicado: (2015)

Improving the quality of Health Care in the Romanian public health system - a priority in the reform process
por: Purcărea, VL, et al.
Publicado: (2015)

Burning mouth syndrome: a review on diagnosis and treatment
por: Coculescu, EC, et al.
Publicado: (2014)

Product policy - the main component of the marketing mix in the Romanian health services
por: Coculescu, BI, et al.
Publicado: (2016)

Orientation to the patient as a marketing strategy in the Romanian healthcare system
por: Coculescu, BI, et al.
Publicado: (2016)

Price and distribution policies in healthcare marketing in Romania
por: Coculescu, BI, et al.
Publicado: (2017)

The Utility of the Lipoprotein-Associated Phospholipase A(2) (Lp-PLA(2)) Assay in Detecting Abnormalities in Lipid Metabolism and Cardiovascular Risk in an HIV-Infected South African Cohort
por: Mayne, Elizabeth S., et al.
Publicado: (2019)

The Yin and Yang dualistic features of autophagy in thermal burn wound healing
por: Ripszky Totan, Alexandra, et al.
Publicado: (2022)

Organ failure as an expression of organ remodeling. Involvement of oxidative stress
por: Dincă, VG, et al.
Publicado: (2013)

Lp-PLA2 Inhibition—The Atherosclerosis Panacea?
por: Karakas, Mahir, et al.
Publicado: (2010)

Association of Carotid Plaque and Serum Lipoprotein-Associated Phospholipase A2 (LP-PLA2) with Postoperative Delirium in Geriatric Patients Undergoing Hip Replacement: A Prospective Cohort Study
por: Wan, Tiantian, et al.
Publicado: (2020)

Antimicrobial resistance induced by genetic changes
por: Coculescu, BI
Publicado: (2009)

Market policy as an innovative element of marketing in the Romanian healthcare services – an approach focused on the patient
por: Coculescu, BI, et al.
Publicado: (2015)

Oxidized phospholipids and lipoprotein-associated phospholipase A(2) as important determinants of Lp(a) functionality and pathophysiological role
por: Tselepis, Alexandros D.
Publicado: (2018)

Lp-PLA(2) Inhibitors for the Reduction of Cardiovascular Events
por: Steen, Dylan L., et al.
Publicado: (2013)

Lp-PLA2 levels in HIV-infected patients
por: Díaz-Pollán, Beatriz, et al.
Publicado: (2014)

Genetic invalidation of Lp-PLA(2) as a therapeutic target: Large-scale study of five functional Lp-PLA(2)-lowering alleles
por: Gregson, John M, et al.
Publicado: (2016)

Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
por: Zhang, Xiaojiu, et al.
Publicado: (2022)

Colocalization methods in pituitary tumorigenesis aged-related in MEN1 KO and wild type mice
por: Stancu, C, et al.
Publicado: (2014)

The Relationship between Intracarotid Plaque Neovascularization and Lp (a) and Lp-PLA2 in Elderly Patients with Carotid Plaque Stenosis
por: Sun, Chang, et al.
Publicado: (2022)

Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease
por: Ma, Sha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f99lambhcdc30fulpe0daf1sun